The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies

BACKGROUND: The effects of filgotinib on patient-reported outcomes (PROs) from 3 trials in patients with active rheumatoid arthritis were investigated. METHODS: Methotrexate (MTX)-naïve patients received filgotinib 200 or 100 mg plus MTX (FIL200+MTX, FIL100+MTX), filgotinib 200 mg monotherapy (FIL20...

Descripción completa

Detalles Bibliográficos
Autores principales: Bingham, Clifton O., Walker, David, Nash, Peter, Lee, Susan J., Ye, Lei, Hu, Hao, Khalid, Javaria Mona, Combe, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722138/
https://www.ncbi.nlm.nih.gov/pubmed/34980223
http://dx.doi.org/10.1186/s13075-021-02677-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722138/
https://www.ncbi.nlm.nih.gov/pubmed/34980223
http://dx.doi.org/10.1186/s13075-021-02677-7

Ejemplares similares